Matthew R. Cooperberg
马修·库珀伯格
MD, MPH
Professor of Urology and Epidemiology & Biostatistics; Helen Diller Family Chair in Urology泌尿学及流行病学与生物统计学教授；海伦·迪勒家族泌尿学讲席教授
👥Biography 个人简介
Matthew Cooperberg is a urologic oncologist at UCSF renowned for developing prostate cancer risk stratification tools, including the CAPRA score, and advancing active surveillance protocols for low-risk disease. His outcomes research has directly shaped guidelines for prostate cancer management worldwide.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Prostate Cancer Risk Stratification
Developed and validated the CAPRA (Cancer of the Prostate Risk Assessment) score, a widely adopted tool for predicting prostate cancer outcomes and guiding treatment decisions after diagnosis.
Representative Works 代表性著作
The CAPRA Score: A Straightforward Tool for Predicting Biochemical Recurrence After Radical Prostatectomy
Cancer (2005)
Introduced and validated a practical preoperative risk score now used globally to guide prostate cancer treatment selection.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 马修·库珀伯格 的研究动态
Follow Matthew R. Cooperberg's research updates
留下邮箱，当我们发布与 Matthew R. Cooperberg（University of California, San Francisco）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment